Cargando…

Crizotinib combined with bronchoscopic interventional treatment in ALK-positive inflammatory myofibroblastic tumor of left main stem bronchus: a case report

BACKGROUND: Inflammatory myofibroblastic tumor (IMT), also known as an inflammatory pseudotumor, is a unique type of intermediate soft tissue tumor that commonly occurred in the lung. Its unclear etiology and cellular activity brought about the confusion not only in naming of it, but also in diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Peng, Wang, Chenchen, Lv, Zechao, Du, Mingxiang, Xu, Ruixin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638830/ https://www.ncbi.nlm.nih.gov/pubmed/37950305 http://dx.doi.org/10.1186/s13019-023-02427-7

Ejemplares similares

Effectiveness of Crizotinib for Inflammatory Myofibroblastic Tumor with ALK mutation
por: Ogata, Misato, et al.
Publicado: (2018)

Endobronchial chondroid hamartoma of left main bronchus and its bronchoscopic management
por: Prasad, Virender Pratibh, et al.
Publicado: (2023)

Efficiency of Crizotinib on an ALK-Positive Inflammatory Myofibroblastic Tumor of the Central Nervous System: A Case Report
por: Chennouf, Anas, et al.
Publicado: (2017)

Crizotinib and Surgery for Long-Term Disease Control in Children and Adolescents With ALK-Positive Inflammatory Myofibroblastic Tumors
por: Trahair, Toby, et al.
Publicado: (2019)

Neoadjuvant crizotinib in ALK-rearranged inflammatory myofibroblastic tumor of the urinary bladder: A case report
por: Nagumo, Yoshiyuki, et al.
Publicado: (2018)

ALK(G1269A) mutation as a potential mechanism of acquired resistance to crizotinib in an ALK-rearranged inflammatory myofibroblastic tumor
por: Michels, Sebastian Y. F., et al.
Publicado: (2017)

ALK-G1269A mutation in epithelioid inflammatory myofibroblastic sarcoma after progression on crizotinib: A case report
por: Xu, Xiaojing, et al.
Publicado: (2019)

Chromoplectic TPM3–ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinib
por: Mansfield, A. S., et al.
Publicado: (2016)

Enlarged mediastinal air cyst in a patient with bronchial diverticula localized in the left main bronchus: a case report with surgical and bronchoscopic findings
por: Ichimura, Hideo, et al.
Publicado: (2017)

Successful treatment of mucoepidermoid carcinoma in the left main bronchus
por: Kawano, Osamu, et al.
Publicado: (2015)

Traumatic tension pneumopericardium and amputation of the left main bronchus
por: Krawczyk, Lech, et al.
Publicado: (2017)

Left main bronchus separation after blunt trauma
por: Lisowska, Hanna, et al.
Publicado: (2017)

CMTR1-ALK: an ALK fusion in a patient with no response to ALK inhibitor crizotinib
por: Du, Xue, et al.
Publicado: (2018)

Inflammatory Myofibroblastic Tumor: A Rare Presentation and an Effective Treatment with Crizotinib
por: Khalil, Sumaira, et al.
Publicado: (2020)

A pilot study of left main bronchus pulse oximetry
por: Wang, XR, et al.
Publicado: (2005)

Foreign Body Aspiration of a Dental Bridge in the Left Main Stem Bronchus
por: Mahmoud, Monay, et al.
Publicado: (2012)

Right transthoracic approach for robotic left main stem bronchus sleeve resection
por: Iriarte, Facundo, et al.
Publicado: (2021)

ALK and ROS1 as targeted therapy paradigms and clinical implications to overcome crizotinib resistance
por: Ye, Mingxiang, et al.
Publicado: (2016)

Epithelioid Inflammatory Myofibroblastic Sarcoma With Poor Response to Crizotinib: A Case Report
por: Aminimoghaddam, Soheila, et al.
Publicado: (2023)

A Unique Case of Adenoid Cystic Carcinoma of the Left Main Bronchus
por: Kobayashi, Toshiaki, et al.
Publicado: (1995)

Left main bronchus resection and reconstruction. A single institution experience
por: Ragusa, Mark, et al.
Publicado: (2012)

Erosion of esophageal stent into left main bronchus causing airway compromise
por: Aneeshkumar, S, et al.
Publicado: (2017)

Segmental resection of the main left bronchus due to adenoid cystic carcinoma
por: Chrząstek, Aleksandra, et al.
Publicado: (2022)

Core Biopsy Diagnosis of ALK Positive Inflammatory Myofibroblastic Tumor of Lung: An Interesting Case
por: Sachdev, Ritesh, et al.
Publicado: (2020)

Successful Retreatment with Crizotinib After Crizotinib-Induced Liver Failure in ALK-Positive Advanced Lung Adenocarcinoma: A Case Report
por: Zhang, Xiangming, et al.
Publicado: (2023)

Outcomes of ALK positive lung cancer patients treated with crizotinib or second-generation ALK inhibitor: a monoinstitutional experience
por: De Carlo, Elisa, et al.
Publicado: (2018)

A case of pulmonary inflammatory myofibroblastic tumor treated with bronchoscopic therapy plus lobectomy
por: Yang, Fan, et al.
Publicado: (2021)

ALK-driven tumors and targeted therapy: focus on crizotinib
por: Murga-Zamalloa, Carlos, et al.
Publicado: (2014)

Incidental left main bronchus obstruction during left-sided double-lumen tube intubation of a patient with an unrecognized tracheal bronchus: A case report
por: Cho, Ho Bum, et al.
Publicado: (2016)

Coexistence of a novel CCNY-ALK and ATIC-ALK double-fusion in one patient with ALK-positive NSCLC and response to crizotinib: a case report
por: Wu, Xuan, et al.
Publicado: (2020)

ALK-positive gastric inflammatory myofibroblastic tumor in an adult with familial adenomatous polyposis and diffuse fundic polyposis
por: Fan, Jun, et al.
Publicado: (2017)

Torsion of left main bronchus during general anesthesia for posterior instrumented spinal fusion
por: Arumainathan, Renuka, et al.
Publicado: (2016)

Solitary extramedullary plasmacytoma of the left main bronchus: A case report and literature review
por: Gao, Limin, et al.
Publicado: (2023)

Bronchoscopic resection of endobronchial inflammatory myofibroblastic tumor: A case report and systematic review of the literature
por: Ray, Animesh, et al.
Publicado: (2014)

ALK negative inflammatory myofibroblastic tumor of the orbit: A masquerading entity
por: Dutta, Vibha, et al.
Publicado: (2014)

ALK Negative Inflammatory Myofibroblastic Tumor Synchronous with Classical Hodgkin Lymphoma
por: Sandoval, Letícia, et al.
Publicado: (2019)

Crizotinib: aseptic abscesses in multiple organs during treatment of EML4-ALK-positive NSCLC
por: Weber, Daniel, et al.
Publicado: (2021)

First-Line Lorlatinib Versus Crizotinib in ALK-Positive NSCLC: Japanese Subgroup Analysis of CROWN
por: Hayashi, Hidetoshi, et al.
Publicado: (2023)

Unusual Late Relapse of ALK-Positive Anaplastic Large Cell Lymphoma Successfully Cleared Using the ALK-Inhibitor Crizotinib: Case Report
por: Harrer, Dennis Christoph, et al.
Publicado: (2020)

Right Main Bronchus Rupture Presenting with Pneumoperitoneum
por: Hong, Seok Beom, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_puc6tal3v26ravpftei80b08h1